Procaps Group, S.A.
https://www.procapsgroup.com/home
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Procaps Group, S.A.
Deal Watch: Innoviva To Buy The Rest Of Entasis For Enterprise Value Of $113m
Already owner of about 60% of the troubled antibiotic firm, Innoviva agrees to pay $2.20 per share for all outstanding stock in Entasis. Roche, KaliVir partner on oncolytic virus therapies.
Company Information
- Industry
- Services
- Contract Manufacturing Organization
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
- Specialty Pharmaceuticals
-
Medical Devices
- Consumables, Central Supplies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Procaps Group, S.A.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice